GFVAX Performance — Goldman Sachs Focused Value Fund, Class A
Data updated: 2025-11-13
GFVAX returned +8.13% over one year to Aug 2025. Annualised returns are +14.40% over 3 years and +13.53% over 5 years. Against its US Large Value category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $150, against $148 for the category, and to $108 over one year, against $110. Volatility over the past three years was 15.15% a year. In the 12 months to Aug 2025 the fund took in a net $2.9M, and assets reached $59.13M.
GFVAX Growth of $100
What $100 invested in Goldman Sachs Focused Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | GFVAX | Category average |
|---|---|---|
| 1 year (Sep 2024 – Aug 2025) | $108 | $110 |
| 3 years (Sep 2022 – Aug 2025) | $150 | $148 |
| 5 years (Sep 2020 – Aug 2025) | $189 | $185 |
| Since data start (Sep 2019 – Aug 2025) | $201 | $194 |
GFVAX Trailing Returns
Total returns to Aug 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +8.13% |
| 3 years (annualised) | +14.40% |
| 5 years (annualised) | +13.53% |
GFVAX Annual Returns
Calendar-year total returns of Goldman Sachs Focused Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Aug) | +4.63% |
| 2024 | +18.74% |
| 2023 | +14.74% |
| 2022 | −6.62% |
| 2021 | +24.60% |
| 2020 | +9.62% |
| 2019 (Sep–Dec) | +10.60% |
GFVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +3.7% | −1.1% | −4.6% | −1.9% | +3.0% | +3.0% | +0.8% | +2.0% | — | — | — | — |
| 2024 | +1.3% | +3.6% | +5.2% | −3.5% | +1.4% | −0.2% | +3.3% | +3.1% | +2.7% | −0.4% | +5.9% | −4.7% |
| 2023 | +5.8% | −3.8% | +0.4% | +0.7% | −2.0% | +6.2% | +3.5% | −3.0% | −3.6% | −3.3% | +8.3% | +5.8% |
| 2022 | −3.5% | +0.2% | +2.3% | −7.1% | +1.8% | −8.7% | +5.9% | −1.7% | −7.7% | +12.4% | +6.6% | −5.1% |
| 2021 | −2.2% | +6.2% | +4.6% | +3.8% | +1.8% | −0.5% | +1.9% | +1.6% | −3.9% | +6.7% | −3.9% | +7.0% |
| 2020 | −2.0% | −9.4% | −14.7% | +10.6% | +3.6% | +0.4% | +4.3% | +5.9% | −2.5% | −1.3% | +13.7% | +3.9% |
| 2019 | — | — | — | — | — | — | — | — | +2.8% | +1.9% | +3.0% | +2.5% |
GFVAX Risk
Risk measures from monthly returns over Sep 2022 – Aug 2025.
- 3-year volatility (annualised): 15.15%
- 3-year Sharpe ratio: 0.65 (vs 4.5% risk-free rate)
- Best month: +12.43% (Oct 2022)
- Worst month: −7.65% (Sep 2022)
GFVAX Fund Flows
Monthly money in and out of Goldman Sachs Focused Value Fund, from SEC Form N-PORT.
- 12-month net flow: $2.9M
- 12-month gross sales (incl. reinvestments): $15.5M
- Sales ÷ redemptions: 1.23×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Aug 2025 | $73K | $1.1M | −$1.0M |
| Jul 2025 | $784K | $2.4M | −$1.7M |
| Jun 2025 | $405K | $280K | $125K |
| May 2025 | $606K | $1.2M | −$560K |
| Apr 2025 | $523K | $903K | −$380K |
| Mar 2025 | $1.6M | $1.1M | $492K |
| Feb 2025 | $2.2M | $993K | $1.2M |
| Jan 2025 | $2.9M | $435K | $2.4M |
| Dec 2024 | $5.2M | $1.8M | $3.4M |
| Nov 2024 | $779K | $398K | $381K |
| Oct 2024 | $182K | $1.9M | −$1.7M |
| Sep 2024 | $267K | $55K | $212K |
GFVAX Assets Under Management
Net assets of Goldman Sachs Focused Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-08-31 | $59.13M |
| 2025-05-31 | $58.26M |
| 2025-02-28 | $60.92M |
| 2024-11-30 | $60.26M |
| 2024-08-31 | $56.69M |
| 2024-05-31 | $55.07M |
| 2024-02-29 | $49.96M |
| 2023-11-30 | $44.85M |
| 2023-08-31 | $47.00M |
| 2023-05-31 | $44.20M |
| 2023-02-28 | $45.72M |
| 2022-11-30 | $46.37M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.